Navigation Links
Scientists identify specific markers that trigger aggressiveness of liver cancer
Date:10/20/2009

d a significant decrease in cancer-free intervals and overall survival for those patients who had a reduction in E-cadherin function," explained Dr. Wu. A downregulated expression of E-cadherin was also associated with large tumor size and multi-nodular tumors.

Results show that co-expression Snail and Twist (transcription factors or proteins that control when genes are switched on or off) indicates the worst prognosis for HCC patients. "Our research is the first to prove that the two proteins (Snail and Twist) work independently, but together promote EMT," noted Dr. Wu.

According to the study, overexpression of Twist is correlated with HCV-related HCC, partially explaining the highly invasive behavior and poor prognosis for patients with this form of liver cancer. Dr Wu added, "Our results provide essential information for determining HCC prognosis in patients and identifies possible new treatments for future HCC management."


'/>"/>

Contact: Dawn Peters
medicalnews@wiley.com
781-388-8408
Wiley-Blackwell
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009).... 30 Kemin Foods, L.C. ("Kemin") a...tive Health Technologies, Ltd. ("OmniActive") have...The parties agree that Kemin,s US Patent No. 5,382...tion, Purification and Recrystallization of Lutein...of" and the reissues of that patent are valid and ...
(Date:11/30/2009)...ov. 30 American Diversif...eased to announce the appointment of Howard M. Mc...y,s Board of Directors. Mr. McEldowney, whose inve... at the Chemical Bank in New York City and subsequ...McEldowney, San Francisco, an institutional money ...
(Date:11/30/2009)..., PHILADELPHIA, Pennsylvania, November 30 /P...ates From Elsevier,s Top Thought Leaders Provide I..., Elsevier, a world leader in healthcare publ...tronic health record (EHR) integrated solutions, t...erican Recovery and Reinvestment,Act (ARRA) update...
(Date:11/30/2009)...ntrol and Prevention estimate that well over one m...th HIV/AIDS. New research from North Carolina Stat... minorities and do not have health insurance, and ...ilitate education and prevention efforts in minori...hich analyzed 90,000 HIV patient hospital visits o...
(Date:11/30/2009)...tal has launched a series of clinical trials in or...atment. This approach involves the application of ...mour cells from the patient him or herself and des...ressive and frequent malignant tumours. The new th...mbined with the standard, first-line treatment inv...
Breaking Medicine News(10 mins):Health News:American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 3Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 4Health News:Research highlights need for national HIV strategy 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6
... Viagrabulk.com is a leading online s...elp for children who are suffering from pulmonary ...Mumbai, Maharashtra (PRWEB) November 3, 2008 -- Vi...Nitric Oxide (INO) treatment is considered as the ...
... 113 children and teens physically victimized by p... to safely avoid conflict and diffuse threats make...guidance is initiated in the immediate aftermath o...ducted on 10- to 15-year-olds treated for assault ...
... it safe and using a two-pronged attack, a novel d... created and tested by an international team of re...e hand, the substance is similar to components of ..., the novel molecule also puts pressure on the tum...
...ic resonance elastography, it could eliminate need...ov. 1 (HealthDay News) -- A new imaging technology...highly accurate in identifying liver diseases and ...ded images (elastograms) that indicate how interna...
..., Ill. A study in the Nov. 1 issue of the journal...neurochemical abnormality in adults with primary i...understanding of the condition,s pathology. , Re...s who have been suffering from primary insomnia fo...
... Origin 100% Pure Ceylon Teas Warm Up Crisp Autumn...rmet Tea Lovers in Your Life, JACKSONVILLE, Fla.,...is the ideal complement to crisp autumn mornings a...and,satisfying hand picked "tea lover" classics fr...
Other Medicine News:Health News:Viagra Bulk Effectively Cures Children with PAH (Pulmonary Arterial Hypertension) 2Health News:Memo to ER docs: Send young victims of violence for 1-on-1 counseling 2Health News:Memo to ER docs: Send young victims of violence for 1-on-1 counseling 3Health News:Substance tackles skin cancer from 2 sides 2Health News:New Imaging Identifies Types of Liver Disease 2Health News:Study links primary insomnia to a neurochemical abnormality in young and middle-aged adults 2Health News:Study links primary insomnia to a neurochemical abnormality in young and middle-aged adults 3Health News:Cook to a Tea 2
(Date:11/30/2009)...re/ -- Reportlinker.com announces that a new marke..., Cardiac Defibrillators - A Worldwide Market ...r.com/p0164315/Cardiac-Defibrillators---A-Worldwid...scular disease (CVD) is one of the foremost causes...ors are prone to arrhythmic disorders, calling the...
(Date:11/30/2009)...ire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ ), ...documentation services, today announced that it ha...Inc. (Nuance) under which MedQuist will now licens...nd processing software for use in SpeechQ of Gener...nition application for all medical disciplines. S...
(Date:11/30/2009)...re/ -- Reportlinker.com announces that a new marke..., Diabetes Diagnostics - A Global Market Persp...7/Diabetes-Diagnostics---A-Global-Market-Perspecti...n by a steady increase in the number of people dia...veloping parts of the world, and increase in inten...
Breaking Medicine Technology:Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9Dominion Diagnostics Continues To Lead Through On Demand Laboratory Science 14387 1Dominion Diagnostics Continues To Lead Through On Demand Laboratory Science 14387 2Rib X Pharmaceuticals Inc Co Founder Thomas A Steitz Ph D Awarded the 2009 Nobel Prize in Chemistry 5296 1Rib X Pharmaceuticals Inc Co Founder Thomas A Steitz Ph D Awarded the 2009 Nobel Prize in Chemistry 5296 2Rib X Pharmaceuticals Inc Co Founder Thomas A Steitz Ph D Awarded the 2009 Nobel Prize in Chemistry 5296 3Rib X Pharmaceuticals Inc Co Founder Thomas A Steitz Ph D Awarded the 2009 Nobel Prize in Chemistry 5296 4NHLBI awards 2411 million for molecular roadmap to chronic lung diseases 10289 1NHLBI awards 2411 million for molecular roadmap to chronic lung diseases 10289 2
...Robert Figlin Highlights Phase 2 Data Showing 31%,...enefit Rate to Perifosine, Used as a Single Agent... Toxicity When Combined with Soraf...Inc. today announced positive phase 1 & 2 data of ...nal cell carcinoma (RCC). In an oral presentation,...
...routine screening, WASHINGTON, Nov. 8 Today, Tes... for Public Health and the North,Carolina Rules Re...lude the,Centers for Disease Control and Preventio...rt of routine medical care. Now in North Carolina,...nt and pre-test counseling is,no longer required.,...
Other Medicine Technology:Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 2Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 3Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 4Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 5Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 6Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 7Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing 2
...m consists of a pistol-grip handpiece available in...e range of couplers that can be used in a variety ...SmartDriver. Modular Pistol-Grip instrument used i...module for drilling, pinning, cutting, and debride...
...m consists of a pistol-grip handpiece available in...e range of couplers that can be used in a variety ...y SmartDriver XT offers significantly increased to...artDriver. The Battery SmartDriver XT accepts the ...
Series 7000 Battery/Electric Large Bone System
...ue Repair System is an evolutionary product for th...gh initially designed specifically for use with th...r is quickly becoming a new standard for use in me...ue method to deliver sutures using a patented deli...
Medicine Products: